Drug
Ft596
Ft596: highest development phase Phase 1, developed by Fate Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Fate Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| FT596 NCT05934097 | Phase 1 | Diffuse Large B Cell Lymphoma |
| FT596 NCT04245722 | Phase 1 | Lymphoma, B-Cell |
Latest
No recent events.
Follow Ft596 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.